Peptide questions · Mazdutide

How long does mazdutide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Mazdutide’s onset is days–2 weeks, its peak effect comes at 48–60 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: Phase 3 trials (GLORY-1, GLORY-2, DREAMS-1, DREAMS-2) and the Chinese label (Xinermei, NMPA 2025). Not FDA-approved.

Mazdutide week by week

The library places six of its research notes on mazdutide on the days they cover, from day 1 to day 336 and on: 5 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The mazdutide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Appetite first, scale laterRandomized trial
Days 29–56 (weeks 5–8)A maintenance dose, not just a stepRandomized trial
Days 57–224 (weeks 9–32)Holding at 4 mgRandomized trial
Days 57–224 (weeks 9–32)The top labelled doseRandomized trial
Days 225–336 (weeks 33–48)Weeks 32 to 48: still moving, more slowlyRandomized trial
From day 337 onA maintenance medication, not a courseClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track mazdutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The mazdutide timeline’s milestones

The library’s timeline for mazdutide marks 6 points from week 1 to week 48, backed by clinical trial data overall.

  • Week 1: Commonly reported: appetite dropping within days, with nausea most likely in the day or two after the injection
  • Week 4: The label's first step: 2 mg for weeks 1 to 4, then 4 mg
  • Week 8: The label's second step: 4 mg to stay on, or 6 mg from week 9 if more weight loss is needed
  • Week 12: Commonly reported: GI side effects settling once the dose holds steady; in GLORY-1 they fell during maintenance
  • Week 32: GLORY-1's main readout: about 10% (4 mg) and 12.5% (6 mg) average loss
  • Week 48: GLORY-1's end: about 11% (4 mg) and 14% (6 mg) average loss, still falling slowly

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why mazdutide takes that long

Mazdutide’s half-life is about 10 days (240 hours), so one dose is about 96.9% cleared after 50 days.

On its schedule (Weekly) the doses overlap, and the level of mazdutide keeps climbing for about 40–50 days before it levels off, so the first 40–50 days run below the level the later weeks hold.

The notes on mazdutide follow the trials’ dose steps, 2mg, 4mg and 6mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Mazdutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, mazdutide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does mazdutide take to work?

Mazdutide’s onset is days–2 weeks, its peak effect comes at 48–60 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does mazdutide reach its peak effect?

By the library’s timeline, mazdutide’s peak effect comes at 48–60 weeks, backed by clinical trial data.

How long is mazdutide usually run?

The library’s timeline gives mazdutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials and label.

What does the library say about the first days on mazdutide?

Its first note on mazdutide, for days 1–28 (weeks 1–4), is “Appetite first, scale later”, resting on randomized trials.

More on mazdutide

Track it in the app

PepVault for iPhone

Track mazdutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo